morbidity and mortality worldwide. The post-stroke immune response has recently emerged
as a new breakthrough target in the treatment strategy for ischemic stroke. Glial cells,
including microglia, astrocytes, and oligodendrocytes, are the primary components of the
peri-infarct environment in the central nervous system (CNS) and have been implicated in
post-stroke immune regulation. However, increasing evidence suggests that glial cells exert …